ArriVent BioPharma, Inc. (AVBP)
Recent Filing Index
| Form | Filed | Qtr End | F_Period | 8K: Earnings Release |
|---|---|---|---|---|
| 10-QLatest | Q1-2026 | 8-K (2026-05-11) · 99.1 | ||
| 10-KLatest | FY-2025 | 8-K (2026-03-05) · 99.1 | ||
| 10-Q | Q3-2025 | 8-K (2025-11-10) · 99.1 | ||
| 10-Q | Q2-2025 | 8-K (2025-08-11) · 99.1 | ||
| 10-Q | Q1-2025 | 8-K (2025-05-12) · 99.1 | ||
| 10-K | FY-2024 | 8-K (2025-03-03) · 99.1 | ||
| 10-Q | Q3-2024 | 8-K (2024-11-14) · 99.1 | ||
| 10-Q | Q2-2024 | 8-K (2024-08-14) · 99.1 | ||
| 10-Q | Q1-2024 | 8-K (2024-05-08) · 99.1 | ||
| 10-K | 8-K (2024-03-28) · 99.1 |
Filing Summary
| Report Name | Notes | Fiscal Period (Annual) | Fiscal Period (Quarter) |
|---|---|---|
| Document and Entity Information | ||
| Statements | ||
| Balance Sheets | ||
| Balance Sheets (P) | ||
| Statements of Operations | — |
|
| Statements of Operations and Comprehensive Loss | ||
| Condensed Statements of Stockholders' Equity (deficit) | — |
|
| Statements of Convertible Preferred Stock (deficit) | — |
|
| Statements of Convertible Preferred Stock and Stockholders' Equity (deficit) | ||
| Condensed Statements of Stockholders' Equity (deficit) (P) | — |
|
| Statements of Convertible Preferred Stock (P) | — |
|
| Statements of Convertible Preferred Stock and Stockholders' Equity (deficit) (P) | ||
| Statements of Cash Flows | ||
| Notes | ||
| Accrued Expenses | ||
| Allist License Agreement | — |
|
| Background | ||
| Commitments and Contingencies | ||
| Commitments, Contingencies, and Collaborations | — |
|
| Common Stock | — |
|
| Convertible Preferred Stock and Common Stock | — |
|
| Cybersecurity Risk Management and Strategy Disclosure | — |
|
| Debt | ||
| Development Stage Risks and Liquidity | — |
|
| Development-stage Risks and Liquidity | ||
| Fair Value Measurements | ||
| Income Taxes | — |
|
| Insider Trading Arrangements | ||
| Insider Trading Policies and Procedures | — |
|
| License and Collaboration Agreements | ||
| License and Collaborative Agreements | ||
| Pay Vs Performance Disclosure | ||
| Prepaid Expenses and Other Current Assets | ||
| Segment Information | ||
| Stock-based Compensation | ||
| Subsequent Event | ||
| Summary of Significant Accounting Policies | ||